v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net loss $ (12,838) $ (19,099)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 2,028 2,842
Non-cash interest income (1) (118)
Extinguishment of debt 120 0
Change in fair value of warrant liability 23 69
Realized gain on equity investment (765) 0
Unrealized income on marketable securities (4) (12)
Loss on derecognition of intangible assets 251 0
Provision for expected credit losses, net of recoveries 110 56
Provision for expected credit losses on contract assets (9) (8)
Stock-based compensation expense 671 201
Changes in assets and liabilities    
Accounts receivable 72 (1,760)
Inventories, net 3,616 (1,351)
Prepaid expenses and other current assets (934) 17,248
Other non-current assets 111 700
Accounts payable 1,207 490
Accrued expenses 175 (18,085)
Deferred revenue (2,202) (3,899)
Other current liabilities 61 (463)
Other non-current liabilities (88) (55)
Net cash used in operating activities (8,396) (23,244)
Investing activities    
Purchase of available-for-sale securities (2,357) (6,656)
Proceeds from sales and maturities of available-for-sale securities 577 8,307
Proceeds from sale of investment in private company 1,719 0
Purchase of property and equipment (6) (77)
Capitalized internally-developed software (1,528) (1,098)
Net cash (used in) provided by investing activities (1,595) 476
Financing activities    
Repayment of term loan (4,777) (556)
Proceeds from revolving credit facility 4,361 0
Tax withholdings on settlement of equity awards (116) 0
Net cash used in financing activities (532) (556)
Effect of exchange rate on cash 227 (152)
Net change in cash, cash equivalents and restricted cash (10,296) (23,476)
Cash, cash equivalents and restricted cash    
Beginning of period 34,620 70,203
End of period 24,324 46,727
Supplemental disclosure of non-cash investing and financing activities    
Capitalization of stock-based compensation to internally developed software $ 2 $ 0